- Home
- REFI vs HRTX Comparison
REFI vs HRTX Comparison
Compare REFI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- HRTX
- Stock Information
- Founded
- REFI 2021
- HRTX 1983
- Country
- REFI United States
- HRTX United States
- Employees
- REFI N/A
- HRTX N/A
- Industry
- REFI Real Estate Investment Trusts
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- REFI Real Estate
- HRTX Health Care
- Exchange
- REFI Nasdaq
- HRTX Nasdaq
- Market Cap
- REFI 314.2M
- HRTX 270.7M
- IPO Year
- REFI 2021
- HRTX 1987
- Fundamental
- Price
- REFI $13.91
- HRTX $1.84
- Analyst Decision
- REFI Strong Buy
- HRTX Strong Buy
- Analyst Count
- REFI 3
- HRTX 3
- Target Price
- REFI $20.00
- HRTX $5.67
- AVG Volume (30 Days)
- REFI 184.0K
- HRTX 1.1M
- Earning Date
- REFI 05-07-2025
- HRTX 05-06-2025
- Dividend Yield
- REFI 14.86%
- HRTX N/A
- EPS Growth
- REFI N/A
- HRTX N/A
- EPS
- REFI 1.88
- HRTX N/A
- Revenue
- REFI $55,534,183.00
- HRTX $144,285,000.00
- Revenue This Year
- REFI $17.87
- HRTX $11.81
- Revenue Next Year
- REFI N/A
- HRTX $15.79
- P/E Ratio
- REFI $7.40
- HRTX N/A
- Revenue Growth
- REFI N/A
- HRTX 13.57
- 52 Week Low
- REFI $12.76
- HRTX $1.04
- 52 Week High
- REFI $16.47
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- REFI 35.57
- HRTX 39.27
- Support Level
- REFI $12.76
- HRTX $1.65
- Resistance Level
- REFI $14.24
- HRTX $2.00
- Average True Range (ATR)
- REFI 0.51
- HRTX 0.14
- MACD
- REFI -0.01
- HRTX -0.03
- Stochastic Oscillator
- REFI 51.57
- HRTX 30.16
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.